PFIZER INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
To Test The Relative Bioavailability Of PF-04191834 When Dosed As An Immediate Release Tablet Compared With Solution Following Single And Multiple Dosing
- First Posted Date
- 2010-02-08
- Last Posted Date
- 2010-02-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 20
- Registration Number
- NCT01064804
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response.
Phase 1
Completed
- Conditions
- Allergic Rhinitis
- Interventions
- First Posted Date
- 2010-02-08
- Last Posted Date
- 2010-06-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 18
- Registration Number
- NCT01064726
- Locations
- 🇺🇸
Pfizer Investigational Site, Omaha, Nebraska, United States
A Phase 1 Study To Estimate The Relative Bioavailability And Food Effect Of PF-04620110 In Healthy Adult Subjects
- First Posted Date
- 2010-02-08
- Last Posted Date
- 2010-03-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT01064492
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer
Completed
- Conditions
- Breast Neoplasm
- First Posted Date
- 2010-02-03
- Last Posted Date
- 2010-12-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1981
- Registration Number
- NCT01061359
Varenicline (Champix®) Special Investigation (Regulatory Post Marketing Commitment Plan)
- First Posted Date
- 2010-02-03
- Last Posted Date
- 2015-02-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 20
- Registration Number
- NCT01061710
Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550
Phase 2
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2010-02-01
- Last Posted Date
- 2012-12-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 111
- Registration Number
- NCT01059864
- Locations
- 🇰🇷
Pfizer Investigational Site, Seoul, Korea, Republic of
Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule
- First Posted Date
- 2010-01-29
- Last Posted Date
- 2011-04-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 36
- Registration Number
- NCT01058824
- Locations
- 🇧🇷
Pfizer Investigational Site, Campinas, Sao Paulo, Brazil
Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD)
Phase 4
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 480
- Registration Number
- NCT01056289
Bioequivalence Study Comparing Linezolid 600 Mg Oral Suspension With 600 Mg Tablet In Chinese Healthy Male Subjects
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2012-02-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 20
- Registration Number
- NCT01055769
- Locations
- 🇨🇳
Pfizer Investigational Site, Shanghai, China
Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012
Completed
- Conditions
- Carcinoma, Renal Cell
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2012-04-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 52
- Registration Number
- NCT01056263
- Locations
- 🇩🇪
Pfizer Investigational Site, Hannover, Germany